Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP938116.RAdl4R3TLgxIXA-DioHKEhv_6n3X_fDyk3ADYrGwmAp48130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP938116.RAdl4R3TLgxIXA-DioHKEhv_6n3X_fDyk3ADYrGwmAp48130_assertion type Assertion NP938116.RAdl4R3TLgxIXA-DioHKEhv_6n3X_fDyk3ADYrGwmAp48130_head.
- NP938116.RAdl4R3TLgxIXA-DioHKEhv_6n3X_fDyk3ADYrGwmAp48130_assertion description "[In this study, we have characterized the T(H)2-like chemokine profile (CCL17, CCL18, CCL20, CCL22) in patients with RRP and asked whether it was modulated in patients who had achieved significant clinical improvement.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP938116.RAdl4R3TLgxIXA-DioHKEhv_6n3X_fDyk3ADYrGwmAp48130_provenance.
- NP938116.RAdl4R3TLgxIXA-DioHKEhv_6n3X_fDyk3ADYrGwmAp48130_assertion evidence source_evidence_literature NP938116.RAdl4R3TLgxIXA-DioHKEhv_6n3X_fDyk3ADYrGwmAp48130_provenance.
- NP938116.RAdl4R3TLgxIXA-DioHKEhv_6n3X_fDyk3ADYrGwmAp48130_assertion SIO_000772 23019074 NP938116.RAdl4R3TLgxIXA-DioHKEhv_6n3X_fDyk3ADYrGwmAp48130_provenance.
- NP938116.RAdl4R3TLgxIXA-DioHKEhv_6n3X_fDyk3ADYrGwmAp48130_assertion wasDerivedFrom befree-20140225 NP938116.RAdl4R3TLgxIXA-DioHKEhv_6n3X_fDyk3ADYrGwmAp48130_provenance.
- NP938116.RAdl4R3TLgxIXA-DioHKEhv_6n3X_fDyk3ADYrGwmAp48130_assertion wasGeneratedBy ECO_0000203 NP938116.RAdl4R3TLgxIXA-DioHKEhv_6n3X_fDyk3ADYrGwmAp48130_provenance.